Browse All

Current Filters

CLEAR FILTER x

TITLE

Program Number:

Management of Myasthenia Gravis Around the Globe: Consensus Guidelines vs. Realities of Practice

Author:Greenberg, Julia   Ganesh, Aravind   Kiprovski, Kiril   Thawani, Sujata   

Session Name:P10: Neuromuscular and Clinical Neurophysiology (EMG): Myasthenia Gravis 3  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P10.018  

Author Institution:NYU Langone Hospital, New York, NY  Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada  NYU-Langone Orthopedic Hospital, New York, NY  

DADA2 Syndrome Causing Cerebrovascular Ischemic Syndromes in Two Asian Siblings

Author:Kong, Yongyao   Chua, Hoe Chin   

Session Name:P10: Cerebrovascular Disease and Interventional Neurology: Innovations in Stroke Therapy and Rehabilitation  

Topic:Cerebrovascular Disease and Interventional Neurology  

Program Number:P10.018  

Author Institution:National Neuroscience Institute, Singapore, Singapore  

A Study on Clinical Profile of Patients Presenting as an Emergency with Movement Disorders to a Tertiary Care Center–A Preliminary Report

Author:Sriram, Chintha Venkata   Biswas, Atanu   Roy, Arijit   Mukherjee, Adreesh   

Session Name:P10: Movement Disorders: Tics and Other Hyperkinetic Movement Disorders  

Topic:Movement Disorders  

Program Number:P10.018  

Author Institution:IPGME&R SSKM, Kolkata, India  North Bengal Medical College, Kolkata, India  

Importance of Bodily Functions in Neuromyelitis Optica Spectrum Disorder from Neurologists’ Perspective

Author:Téllez Lara, Nieves   Gómez, Rocío   Aguado-Valcarcel, Marta   Sepúlveda, María   Cobo-Calvo, Álvaro   Orviz-García, Aida   Díaz Sánchez, María   Boyero, Sabas   Rebollo, Pablo   Maurino, Jorge   

Session Name:P10: Autoimmune Neurology: NMOSD  

Topic:Autoimmune Neurology  

Program Number:P10.018  

Author Institution:Hospital Clínico Universitario de Valladolid, Valladolid, Spain  Medical Department, Roche Farma, Madrid, Spain  Hospital Universitario Álvaro Cunqueiro, Vigo, Spain  Hospital Clínic de Barcelona, Barcelona, Spain  Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d'Hebron, Barcelona, Spain  Fundacion Jimenez Diaz, Madrid, Spain  Hospital Universitario Virgen del Rocío, Sevilla, Spain  Hospital Universitario Cruces, Bilbao, Spain  IQVIA, Madrid, Spain  

The Bruton’s Tyrosine Kinase Inhibitor Remibrutinib Exhibits No Impact on Serum Immunoglobulin Levels: Insights from Chronic Spontaneous Urticaria

Author:Bermel, Robert   Carr, Warner   Chitnis, Tanuja   Dörner, Thomas   Hayama, Koremasa   Hide, Michihiro   Maurer, Marcus   Montalban, Xavier   Sussman, Gordon   Wiendl, Heinz   Dahale, Swapnil   DeLasHeras, Virginia   Haemmerle, Sibylle   Kieseier, Bernd   Lheritier, Karine   Zharkov, Artem   Willi, Roman   Giménez-Arnau, Ana   

Session Name:P10: Multiple Sclerosis: Clinical Trials and Therapeutics (including Safety) 3  

Topic:Multiple Sclerosis  

Program Number:P10.018  

Author Institution:Cleveland Clinic, Cleveland, OH  Allergy and Asthma Associates of Southern California, and Southern California Research, Mission Viejo, CA  Brigham and Women's Hospital, Boston, MA  Charite Universitätsmedizin Berlin, Berlin, Germany  Nihon University School of Medicine, Tokyo, Japan  Hiroshima Citizens Hospital, Minami-ku, Japan  Charité - Universitätsmedizin Berlin, Berlin, Germany  Vall Hebron University Hospital-Multiple Sclerosis Centre of Catalonia, Barcelona, Spain  Gordon Sussman Clinical Research Inc., North York, ON, Canada  University of Muenster, Muenster, Germany  IQVIA, Mumbai, India  Novartis Pharma AG, Basel, Switzerland  Novartis, Basel, Switzerland  Hospital del Mar - IMIM, Universitat Pompeu Fabra, Barcelona, Spain